Abstract

Echinacea purpurea, sometimes referred to as purple coneflower, is well-known and has a long history of usage in traditional medicine for a variety of illnesses. A well-known medicinal herb called Echinacea purpurea has attracted interest for its conceivable anti-inflammatory capabilities. A wide range of experiments that were carried out both in vitro and in vivo are covered in this review's comprehensive evaluation of the literature already available on the topic. The study opens by emphasizing the rising incidence of inflammatory disorders and the need for efficient natural treatments. It looks into the phytochemical makeup of Echinacea purpurea, highlighting its bioactive elements such alkamides, polysaccharides, and flavonoids, which have proven anti-inflammatory potential via a variety of pathways. The plant has a wide variety of bioactive components, which may contribute to its possible anti-inflammatory capabilities. These components include phenolic compounds, alkamides, polysaccharides, and flavonoids. With a focus on its mechanisms of action, preclinical and clinical research, and prospective therapeutic uses, this review seeks to completely analysis techniques the scientific data demonstrating Echinacea purpurea's anti-inflammatory effectiveness. Echinacea purpurea has anti-inflammatory properties, supporting its promise as a natural treatment for inflammatory diseases.

Description